Thrombotic thrombocytopenic purpura and neurologic manifestations – Case report and integrative review

Introduction: Thrombotic thrombocytopenic Purpura (TTP) is a rare and pontentially life-threatening condition, it occurs due a deficiency of ADAMTS13 enzyme complex, leading to formation of microthrombi in the microvasculature, what may cause manifestations in several organs. The most common tissues afected are the renal and neurological ones, with some severe complications. The best treatmente nowadays is Plasma Exchange (PEx). The most commom neurologic manifestation of TTP is Headache, but stroke, mental confusion and others can also be present.   Objective: To describe a case of atypical neurologic manifestation of TTP and to perform na integrative review. Case Report: Female patient, 59 years old was admitted to the emergency room with importante dyspneia. She also presented hypotension, tachycardia and low oxygen-hemoglobin saturation. After these symptoms were estabilized, she was hospitalized for further investigation. During her hospitalization, she developed microangiophatic anemia, thrombocytopenia and renal failure, she also had a historic of neurologic manifestations such as strenght decrease in lower and upper limbs, gagging, dysphagia. She was diagnosed with TTP and and it was indicated hospital transference to her for realizing this procedure, Although, in the thirteenth day of hospitalization, the patient had and irreversible cardiac arrest.  Discussion: The Thrombotic thrombocytopenic purpura is a rare disease that affects priorly women and its a rara condition in many countries around the world. We present a case of atypical neurologic manifestations in a patient with no risk factors. We also know that this disease is treatable with Plasma Exchange and this procedure changed the morality rate which used to be about 80% and after PEX is about of 20%. The most common neurologic manifestation is headache. Conclusion:  We have to be alert in patients in the emergency departament with neurologic manifestations. Once the patient did not present any of the most commom neurologic symptons, it is a rare case.

[1]  J. Atallah,et al.  Antineoplastic agents and thrombotic microangiopathy , 2017, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

[2]  F. Peyvandi,et al.  Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura. , 2016, The New England journal of medicine.

[3]  T. Mehmood,et al.  Management of Thrombotic Microangiopathic Hemolytic Anemias with Therapeutic Plasma Exchange: When It Works and When It Does Not. , 2016, Hematology/oncology clinics of North America.

[4]  M. Marques,et al.  Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs). , 2016, American journal of clinical pathology.

[5]  P. Mannucci,et al.  The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring. , 2015, Thrombosis research.

[6]  C. Abrams,et al.  How I treat refractory thrombotic thrombocytopenic purpura. , 2015, Blood.

[7]  S. Cataland,et al.  Headache prevalence following recovery from TTP and aHUS , 2015, Annals of Hematology.

[8]  S. Dethy,et al.  Stroke in thrombotic thrombocytopenic purpura induced by thyrotoxicosis: a case report. , 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[9]  G. Váradi,et al.  Thrombotic thrombocytopenic purpura and cardiac papillary fibroelastoma: a 'unique coexistence'. , 2013, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[10]  S. Vesely,et al.  Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. , 2013, Blood.

[11]  Zaid Alirhayim,et al.  DRESS syndrome and thrombotic thrombocytopaenic purpura: are they related? , 2012, BMJ Case Reports.

[12]  C. Kessler,et al.  Thrombotic thrombocytopenic purpura: a hematological emergency. , 2012, The Journal of emergency medicine.

[13]  A. Saxena,et al.  Bortezomib-induced thrombotic thrombocytopaenic purpura , 2012, BMJ Case Reports.

[14]  R. Colvin,et al.  Case records of the Massachusetts General Hospital. Case 37-2010. A 16-year-old girl with confusion, anemia, and thrombocytopenia. , 2010, The New England journal of medicine.

[15]  E. Wijdicks,et al.  Renal failure and posterior reversible encephalopathy syndrome in patients with thrombotic thrombocytopenic purpura. , 2010, Archives of neurology.

[16]  R. Lipton,et al.  Headache in Thrombotic Thrombocytopenic Purpura: Two Cases With Pathophysiological Considerations , 2010, Headache.

[17]  S. Vesely,et al.  Survival and relapse in patients with thrombotic thrombocytopenic purpura. , 2010, Blood.

[18]  P. Galieni,et al.  High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study , 2010, Annals of Hematology.

[19]  Andrew Wang,et al.  Clinical problem-solving. Taken out of context. , 2008, The New England journal of medicine.

[20]  David F.M. Brown,et al.  Rash and neurological symptoms. , 2007, The Journal of emergency medicine.

[21]  H. Tsai The molecular biology of thrombotic microangiopathy. , 2006, Kidney international.

[22]  H. Tsai Current concepts in thrombotic thrombocytopenic purpura. , 2006, Annual review of medicine.

[23]  K Sauer,et al.  [Clinical problem solving]. , 2001, Praxis.

[24]  R. Howard,et al.  Coma in thrombotic thrombocytopenic purpura , 1999, Journal of Neurology Neurosurgery & Psychiatry.

[25]  J. George Thrombotic Thrombocytopenic Purpura , 1988 .